iOS app Android app More

GE Ignored Omniscan Safety Advice And May Have Hid Evidence From FDA, Documents Show

First Posted: 06/15/10 06:12 AM ET Updated: 05/25/11 05:10 PM ET

Ge Dnu

ProPublica:

GE Healthcare ignored the advice of its own safety experts to "proactively" restrict use of its imaging drug, Omniscan, after reports in Europe linked the drug to a potentially crippling disease, according to a newly unsealed order in a lawsuit against the company.

The recommendation came at a May 2006 meeting convened by the company's vice president for drug safety. But instead of immediately alerting doctors to stop using the drug in high-risk patients, GE spent the next year arguing that approach wasn't necessary, even as some government and radiological experts favored such a ban.

Read the whole story: ProPublica

FOLLOW HUFFPOST BUSINESS
Subscribe to the HuffPost Money newsletter!
Filed by T.J. Ortenzi  |